S&P Global Other Non-Current Liabilities decreased by 30.4% to $771.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.4%, from $833.00M to $771.00M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 11.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $749.00M | $715.00M | $660.00M | $488.00M | $441.00M | $445.00M | $489.00M | $476.00M | $495.00M | $507.00M | $522.00M | $595.00M | $820.00M | $933.00M | $815.00M | $833.00M | $1.19B | $1.17B | $1.11B | $771.00M |
| QoQ Change | — | -4.5% | -7.7% | -26.1% | -9.6% | +0.9% | +9.9% | -2.7% | +4.0% | +2.4% | +3.0% | +14.0% | +37.8% | +13.8% | -12.6% | +2.2% | +43.1% | -2.1% | -5.1% | -30.4% |
| YoY Change | — | — | — | — | -41.1% | -37.8% | -25.9% | -2.5% | +12.2% | +13.9% | +6.7% | +25.0% | +65.7% | +84.0% | +56.1% | +40.0% | +45.4% | +25.1% | +35.8% | -7.4% |